Concepedia

Tessa Brabander

TB

Statistics

Publications

32

Citations

1.9K

H-Index

20

Active since

2015

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

Erasmus MC Cancer Institute

Cancer Genomics Centre

TRIUMF

Tessa Brabander is an author at Erasmus MC specializing in medicine, oncology, and nuclear medicine.

Publications per year

2015–2025

32

Publications

32

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen et al. · Clinical Cancer Research · 2017 · 604 citations

Medicine, Oncology, Pharmacology +17

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

Wouter A. van der Zwan, Tessa Brabander, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 137 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors

Wouter T. Zandee, Tessa Brabander, Anela Blažević et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 135 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate

Esther I. van Vliet, Casper H.J. van Eijck, Ronald R. de Krijger et al. · Journal of Nuclear Medicine · 2015 · 122 citations · Full text

Medicine, Oncology, Surgery +17

Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE

Wouter T. Zandee, Richard A. Feelders, Daan A. Smit Duijzentkunst et al. · European Journal of Endocrinology · 2019 · 77 citations · Full text

Medicine, Nuclear Medicine, Oncology +10

1–5 of 32